These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21168769)

  • 1. Consequences of cisplatin binding on nucleosome structure and dynamics.
    Todd RC; Lippard SJ
    Chem Biol; 2010 Dec; 17(12):1334-43. PubMed ID: 21168769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 1,2-d(GpG) cisplatin intrastrand cross-link influences the rotational and translational setting of DNA in nucleosomes.
    Ober M; Lippard SJ
    J Am Chem Soc; 2008 Mar; 130(9):2851-61. PubMed ID: 18269283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin damage overrides the predefined rotational setting of positioned nucleosomes.
    Ober M; Lippard SJ
    J Am Chem Soc; 2007 May; 129(19):6278-86. PubMed ID: 17432860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleotide excision repair from site-specifically platinum-modified nucleosomes.
    Wang D; Hara R; Singh G; Sancar A; Lippard SJ
    Biochemistry; 2003 Jun; 42(22):6747-53. PubMed ID: 12779329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription inhibition by platinum-DNA cross-links in live mammalian cells.
    Ang WH; Myint M; Lippard SJ
    J Am Chem Soc; 2010 Jun; 132(21):7429-35. PubMed ID: 20443565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple states of stalled T7 RNA polymerase at DNA lesions generated by platinum anticancer agents.
    Jung Y; Lippard SJ
    J Biol Chem; 2003 Dec; 278(52):52084-92. PubMed ID: 14534300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platinum anticancer drug damage enforces a particular rotational setting of DNA in nucleosomes.
    Danford AJ; Wang D; Wang Q; Tullius TD; Lippard SJ
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12311-6. PubMed ID: 16116097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of DNA--platinum adduct recognition by prokaryotic and eukaryotic DNA-dependent RNA polymerases.
    Corda Y; Job C; Anin MF; Leng M; Job D
    Biochemistry; 1993 Aug; 32(33):8582-8. PubMed ID: 7689335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualizing inhibition of nucleosome mobility and transcription by cisplatin-DNA interstrand crosslinks in live mammalian cells.
    Zhu G; Song L; Lippard SJ
    Cancer Res; 2013 Jul; 73(14):4451-60. PubMed ID: 23695549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin.
    Takahara PM; Rosenzweig AC; Frederick CA; Lippard SJ
    Nature; 1995 Oct; 377(6550):649-52. PubMed ID: 7566180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site selectivity of platinum anticancer therapeutics.
    Wu B; Dröge P; Davey CA
    Nat Chem Biol; 2008 Feb; 4(2):110-2. PubMed ID: 18157123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects.
    Lovejoy KS; Todd RC; Zhang S; McCormick MS; D'Aquino JA; Reardon JT; Sancar A; Giacomini KM; Lippard SJ
    Proc Natl Acad Sci U S A; 2008 Jul; 105(26):8902-7. PubMed ID: 18579768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA polymerases react differently at d(ApG) and d(GpG) adducts in DNA modified by cis-diamminedichloroplatinum(II).
    Corda Y; Anin MF; Leng M; Job D
    Biochemistry; 1992 Feb; 31(7):1904-8. PubMed ID: 1536834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin.
    Gelasco A; Lippard SJ
    Biochemistry; 1998 Jun; 37(26):9230-9. PubMed ID: 9649303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platinum drug adduct formation in the nucleosome core alters nucleosome mobility but not positioning.
    Wu B; Davey CA
    Chem Biol; 2008 Oct; 15(10):1023-8. PubMed ID: 18940663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA interactions of bifunctional dinuclear platinum(II) antitumor agents.
    Zaludová R; Zákovská A; Kasparková J; Balcarová Z; Kleinwächter V; Vrána O; Farrell N; Brabec V
    Eur J Biochem; 1997 Jun; 246(2):508-17. PubMed ID: 9208945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of platinum-DNA damage by poly(ADP-ribose) polymerase-1.
    Zhu G; Chang P; Lippard SJ
    Biochemistry; 2010 Jul; 49(29):6177-83. PubMed ID: 20550106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of cisplatin and analogues with DNA in reconstituted chromatin.
    Galea AM; Murray V
    Biochim Biophys Acta; 2002 Dec; 1579(2-3):142-52. PubMed ID: 12427549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
    Kasparkova J; Novakova O; Farrell N; Brabec V
    Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.
    Ohndorf UM; Rould MA; He Q; Pabo CO; Lippard SJ
    Nature; 1999 Jun; 399(6737):708-12. PubMed ID: 10385126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.